Analysis of Five Year Survival Rate on Thyroid Cancer
Patients
at Dr. M. Djamil Hospital Padang
By: Oktahermoniza, Wirsma Arif Harahap*, Tofrizal **, and Rosfita Rashid ***
Departement of Surgery, Faculty of Medicine, Andalas University, Dr. M. Djamil Hospital, Padang, Indonesia
______________________________________________________________________________________
ABSTRACT
ABSTRACT
Background: Thyroid cancer is a rare cancer, but is
the most common cancer in endocrine organ. The purpose of this study was to determine
the five-year survival thyroid cancer patients in the management at Hospital Dr.
M. Djamil Padang from January 2007 to December 2011.
Methods: Subjects were 117 patients in the management
of thyroid cancer in Hospital Dr. M. Djamil Padang from January 2007 to
December 2011. Data were analyzed with the approach of survival time using Kaplan-Meier method and log rank test.
Results: Median age 39 years (range, 11 to 77
years), median follow-up time of 32 months (range, 1 to 70 months), median tumor
size was 6 cm (range, 1 to 16 cm). Obtained 100 (85.5%)%) patients with tumor-free
survival, 7 (6%) patients with local recurrence, 1 (0.9%) distant metastases,
and 9 (7.7%) patients died. Overall five survival rate of thyroid cancer in
this study was 92.3%. Factors of age, tumor size and histopathological type was
significantly associated with survival (P = 0.000), (P = 0.046) and (P = 0.000).
While the factors gender, type of surgery, and adjuvant therapy had no significant
association with survival.
Conclusion: Age, tumor size, and type of histopathology
associated significantly with survival. Gender, type of surgery, and adjuvant
therapy did not significantly associated with survival.
Key Words: Age, tumor size, type of Histopathology, Survival, Thyroid Cancer.
______________________________________________________________________________________
*
Departement of Surgery, Faculty of
Medicine, Andalas University, Dr. M. Djamil Hospital, Padang, Indonesia
** The Anatomical Pathology Faculty of Medicine, University Andalas
** Department of Public Health Faculty of Medicine Unand
No comments:
Post a Comment